// App-Quantinova.ai

PB2039 : Standard Versus Higher Intensity Anticoagulation for Patients with Mechanical Aortic Valve Replacement and Additional Risk Factors for Thromboembolism: A Multi-center Registry Analysis

Researchers

Presenter

  • S. Hanigan

Principal Investigators

  • X. Kong

  • B. Haymart

  • S. Kaatz

  • G. Krol

  • V. Shah

  • J. Kozlowski

  • J.B. Froehlich

  • G.D. Barnes

Medical Centers

  • Michigan Medicine, Frankel Cardiovascular Center, Ann Arbor, United States

  • Henry Ford Hospital, Detroit, Michigan, United States

  • DMC-Huron Valley Sinai, Commerce Charter Twp, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Warfarin

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved